MARC2 antibody (AA 270-300)

Catalog No. ABIN7873150

The Rabbit Polyclonal anti-MARC2 antibody (ABIN7873150) specifically detects MARC2 in WB, IHC (p) and FACS. The antibody is reactive with Human samples.

Quick Overview for MARC2 antibody (AA 270-300) (ABIN7873150)

Target: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MARC2 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Product Details anti-MARC2 Antibody

Binding Specificity: AA 270-300

Purpose: Mitochondrial amidoxime reducing component 2 Antibody / mARC2 / MTARC2

Purification: Antigen affinity purified

Immunogen: A portion of amino acids 270-300 from the human protein was used as the immunogen for the Mitochondrial amidoxime reducing component 2 antibody.

Isotype: Ig Fraction

Application Details

Application Notes: The stated application concentrations are suggested starting points. Titration of the Mitochondrial amidoxime reducing component 2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the Mitochondrial amidoxime reducing component 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for MARC2

Target: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Alternative Name: Mitochondrial amidoxime reducing component 2

Background: Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.

UniProt: Q969Z3